House of Health
Meet The Team

Dr Nadir Abbas

Consultant Gastroenterologist & Hepatologist  ·  PhD (Liver Diseases)

Director of Private Gut and Liver Services at House of Health

Dr Nadir Abbas - Consultant Gastroenterologist & Hepatologist
Consultant Gastroenterologist & Hepatologist

Dr Nadir Abbas

Dr Nadir Abbas is a Consultant Gastroenterologist and Hepatologist at University Hospitals Birmingham NHS Foundation Trust, holding a PhD from the Institute of Immunology and Immunotherapy and the NIHR Birmingham Biomedical Research Centre — one of the UK’s most prestigious biomedical research institutions. The University of Birmingham ranks #14 globally for gastroenterology and hepatology research.

He trained at the Queen Elizabeth Hospital liver unit, one of the largest liver transplant units in Europe, and works as a full-time NHS consultant at UHB seeing the full breadth of gastroenterology and hepatology conditions.

Professional Memberships

  • Royal College of Physicians (RCP)
  • British Society of Gastroenterology (BSG)
  • British Association for the Study of the Liver (BASL)
  • European Association for the Study of the Liver (EASL)

Hospital & Clinical Affiliations

  • University Hospitals Birmingham NHS Foundation Trust
  • Director of Private Gut and Liver Services at House of Health
  • PhD - University of Birmingham
MBBS BA Hons MRCP (Gastro) FEBGh FRCPE PhD (Birmingham) Dual CCT

Read Verified Patient Reviews

See what patients say about their experience with Dr Nadir Abbas on Doctify, an independent and verified review platform.

Read Verified Patient Reviews on Doctify
Biography

Clinical & Academic Biography

Dr Nadir Abbas is a Consultant Gastroenterologist and Hepatologist at University Hospitals Birmingham NHS Foundation Trust, holding a PhD from the Institute of Immunology and Immunotherapy and the NIHR Birmingham Biomedical Research Centre — one of the UK’s most prestigious biomedical research institutions. The University of Birmingham ranks #14 globally for gastroenterology and hepatology research.

He trained at the Queen Elizabeth Hospital liver unit, one of the largest liver transplant units in Europe, and works as a full-time NHS consultant at UHB seeing the full breadth of gastroenterology and hepatology conditions.

With a peer-reviewed publication record spanning four continents, Dr Abbas has positioned himself as one of the UK’s leading hepatology researchers. His work encompasses landmark national audits, international multicentre outcome studies, and practice-defining clinical guidance — reaching over 10,000 patients globally across more than 15 countries.

He has served as investigator on pivotal studies in primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), acute-on-chronic liver failure (ACLF), cirrhosis and surgical risk, and portal hypertension. His publications appear in the world’s most prestigious journals including the Journal of Hepatology, Hepatology, The Lancet Gastroenterology & Hepatology, and Clinical Gastroenterology and Hepatology.

He has presented at the European Association for the Study of the Liver (EASL) — including a podium presentation at EASL 2022 — and is a recognised contributor to British Society of Gastroenterology clinical guidance. He served as national chair for hepatology trainees at BASL for two years and is an active pharmaceutical industry collaborator investigating novel treatments in liver research.

21+

GI/HEPATOLOGY PUBLICATIONS

10+

MULTICENTRE STUDIES

10,000+

PATIENTS ACROSS STUDIES

15+

COUNTRIES — DATA

10+

TOP-TIER JOURNAL PUBS

3

NATIONAL AUDITS/SURVEYS

Primary Biliary Cholangitis (PBC)

Lead investigator on multiple national & international cohort studies; national audit of 8,968 patients; first-author studies in Journal of Hepatology, Hepatology, CGH, JHEP Reports & APT.

Primary Sclerosing Cholangitis (PSC)

Emerging drug reviews and quantitative imaging studies; non-invasive biomarker assessment; expert command of PSC therapeutics pipeline.

Cirrhosis & Surgical Risk

Lead author on national BSG guidance document; precision medicine framework for cirrhotic patients undergoing non-hepatic surgery.

Acute-on-Chronic Liver Failure (ACLF)

Invited expert review in Expert Review of Gastroenterology & Hepatology; novel treatment paradigm analysis.

Portal Hypertension & Liver Stiffness

Contributing author on landmark studies examining liver stiffness measurement as prognostic tool in PBC across international cohorts.

Affiliations

Institutional Affiliations & Leadership

University Hospitals Birmingham NHS FT

Consultant Gastroenterologist & Hepatologist

University of Birmingham — Institute of Immunology & Immunotherapy

PhD-Centre for Liver and Gastroenterological Research

NIHR Birmingham Biomedical Research Centre

Former Clinical Researcher — Liver & GI Theme

Global PBC Study Group

Contributing Investigator

ERNRare-Liver (European Reference Network)

Contributing Member

British Society of Gastroenterology (BSG)

Fellow & Guidance Author — Liver Section

European Association for the Study of the Liver (EASL)

Member

British Association for Study of the Liver (BASL)

Member — Former National Trainee Chair

Conditions Treated

Clinical Expertise & Conditions Treated

Dr Nadir Abbas provides a definitive, research-led approach to a broad spectrum of gastrointestinal and liver conditions. By combining his clinical role at a leading transplant centre with his PhD background, he offers precision diagnostics for both common and complex cases.

Specialist Hepatology (Liver)

  • Autoimmune Liver DiseaseComprehensive management of PBC, PSC, and Autoimmune Hepatitis, utilising the latest international therapeutic pipelines and second-line treatments.
  • Advanced HepatologyExpert evaluation of abnormal liver function tests (LFTs), fatty liver (MASLD/MASH), alcohol-related disease, and viral hepatitis.
  • Cirrhosis & ComplicationsSpecialist care for portal hypertension, ascites, and surgical risk optimisation for patients with advanced liver disease.

Gastroenterology & Diagnostics

  • Diagnostic GastroscopyPrecision endoscopic evaluation for persistent indigestion, reflux (GORD), and screening for stomach or oesophageal concerns.
  • Functional Gut DisordersEvidence-based investigation into IBS, SIBO, and chronic bloating, focusing on identifying root causes rather than merely managing symptoms.
  • Change in Bowel HabitsRapid assessment of altered bowel patterns, unexplained weight loss, and iron deficiency anaemia to ensure early detection and peace of mind.
PBC Excellence Suite

Dr Nadir’s PBC Specialist Care

Because Dr Abbas holds a PhD specifically in PBC, patients travel from all over the country to see him. He is a renowned primary biliary cholangitis specialist who offers a specialist management plan tailored to each patient.

As an autoimmune liver disease expert UK, his research-led approach provides hope for complex cases. He is also a highly skilled autoimmune hepatitis consultant, working hard to protect your liver from immune system attacks.

If you do not respond well to standard UDCA medicine, we provide exclusive access to advanced therapies.

Why Choose Dr Nadir

Why Patients Seek Dr Nadir

PhD-Led Insights

Access to diagnostic frameworks developed at the NIHR Birmingham Biomedical Research Centre.

National Authority

Care guided by the same expert who authors the National BSG clinical standards.

Rapid Diagnostics

Streamlined access to FibroScan and high-definition endoscopy for immediate answers.

Compassionate Clarity

A listening-first approach that translates complex medical data into a clear, actionable recovery plan.

Advanced PBC Care

How Dr Nadir’s Care Helps You

PhD-Led Expertise

Specialist care for high-risk cases and patients who do not respond well to standard UDCA medicine

Therapeutic Innovation

Expert access to advanced, second-line therapies like Ocaliva, Iqirvo (Elafibranor), and Bezafibrate

Symptom Management

Evidence-based plans to safely stop debilitating PBC fatigue and severe skin itch

Prognostic Monitoring

Advanced use of painless FibroScan technology and exact blood tests to track your liver health

International

International Education & Collaborations

EASL School on Autoimmune Liver Conditions group photo, Larissa Greece

EASL School on Autoimmune Liver Conditions — Larissa, Greece

Attending the prestigious EASL School on Autoimmune Liver Conditions in Larissa, Greece — a highly selective European programme bringing together hepatology trainees and faculty from across the continent to advance expertise in autoimmune liver diseases including primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis.

This programme reflects a commitment to staying at the forefront of hepatology through international collaboration, evidence synthesis, and direct engagement with global liver disease experts.

Primary Biliary CholangitisPrimary Sclerosing CholangitisAutoimmune HepatitisCholestatic Liver DiseaseEASL FacultyInternational Training

EASL School on Portal Hypertension — Freiburg, Germany

Attending the EASL School on Portal Hypertension at the Universitätsklinikum Freiburg, Germany — the birthplace of the TIPSS (Transjugular Intrahepatic Portosystemic Shunt) procedure. This school was held at one of the most historically significant institutions in hepatology, home to Professor Martin Rossle, the pioneer who invented the TIPSS procedure.

Being taught portal hypertension management at the institution where TIPSS was conceived, by the faculty who shaped the field, represents a unique and formative experience in advanced hepatology training.

Portal HypertensionTIPSS ProcedureCirrhosis ComplicationsVarices ManagementProf Martin RossleFreiburg — Birthplace of TIPSS
EASL School on Portal Hypertension group photo, Freiburg Germany
Publications

Peer-Reviewed Publications

Publication Record — GI & Liver Disease

Listed in reverse chronological order. Source: PubMed (pubmed.ncbi.nlm.nih.gov/?term=nadir+abbas), verified March 2026. Nadir Abbas is highlighted where listed as author.

Journal of Hepatology

IF ~25

3 publications

Hepatology

IF ~17

1 publication

The Lancet GH

IF ~30

1 publication

Clin. Gastro & Hepatology

IF ~14

2 publications

JHEP Reports

IF ~8

2 publications

Frontline Gastroenterology

BSG Journal

4 publications incl. national guidance

Alimentary Pharm & Ther

IF ~7

2 publications

Expert Review GH

IF ~5

2 invited reviews

Current Opinion in Pharm

IF ~6

1 invited review

Abbas N, Smith R, Lytvyak E, Scaravaglio M, Halliday N, et al.

Alimentary Pharmacology & Therapeutics2026 · Feb;63(4):494–506 · PMID: 40977287

First lead author study demonstrating heightened clinical risk with OCA non-response in PBC

Wong YJ, Lam L, Soret PA, …, Abbas N, Trivedi P, et al. (Global & ERN Rare-Liver PBC Study Groups)

Journal of Hepatology2026 · Feb;84(2):275–283 · PMID: 41047080

Journal of Hepatology — global multicentre; 15+ countries; landmark prognostic comparison

Smith R, Burke L, Abbas N, Aspinall RJ, Thorburn D, et al. (UK-PBC Audit Group)

JHEP Reports2025 · Apr;7(9):101422 · PMID: 40810101

UK national care bundle quality improvement study in PBC

Werner E, van Hooff MCB, …, Abbas N, …, Trivedi PJ, van der Meer AJ (Global PBC Study Group/ERN RARE-LIVER)

Clinical Gastroenterology and Hepatology2025 · Oct;23(11):1935–1942 · PMID: 40246040

International Delphi consensus — patient-centred care in PBC; 15+ countries

Faulkes RE, Morris S, Bolimowska O, Rehman Z, Abbas N, Dasari BVM, et al.

Frontline Gastroenterology2025 · Feb;16(5):e102773 · PMID: 40933942

HCC transplant assessment outcomes — clinical practice impact

Corpechot C, Lemoinne S, Soret PA, Hansen B, …, Abbas N, Trivedi P, et al. (Global & ERN Rare-Liver PBC Study Groups)

Hepatology2024 · Jan;79(1):39–48 · PMID: 37399238

Hepatology — highest-impact liver journal; international multicentre; treatment response paradigm

Lam L, Soret PA, Lemoinne S, Hansen B, …, Abbas N, Trivedi P, et al. (Global & ERN Rare-Liver PBC Study Groups)

Clinical Gastroenterology and Hepatology2024 · Dec;22(12):2432–2441 · PMID: 39019421

First large-scale longitudinal study of liver stiffness dynamics in PBC

Montano-Loza AJ, Lytvyak E, Hirschfield G, Hansen BE, … Abbas N, Trivedi PJ, et al. (Global PBC Study Group)

Journal of Hepatology2024 · Oct;81(4):679–889 · PMID: 38821348

Journal of Hepatology — joint transplant-recurrent PBC prognostication: global cohort

Trivedi PJ, Arndt K, Abbas N, Telford A, Young L, Banerjee R, et al.

Alimentary Pharmacology & Therapeutics2024 · Jun;59(11):1569–1576 · PMID: 38571384

Prospective non-invasive imaging study in PSC — novel disease monitoring approach

Abbas N, Culver EL, Thorburn D, Halliday N, Crothers H, et al.

Clinical Gastroenterology and Hepatology2023 · Jun;21(6):1661–1670 · PMID: 35963118

Lead author — 13 centre UK multicentre study; 467 patients; national practice-changing evidence

Abbas N, Culver EL, Flack S, Baine Y, et al. (UK-PBC Audit Group)

JHEP Reports2023 · Oct;5(10):100901 · PMID: 38889146

Lead author — national population-based audit; 8,948 patients; EASL 2022 Platform Presentation

Abbas N, Falkiewicz J, Patch D, Stanley AJ, Mookerjee R, Tsochatzis E, et al.

Frontline Gastroenterology2023 · Mar;14(5):359–370 · PMID: 37381186

Lead author — national BSG clinical guidance document; shaping surgical risk practice in UK

Abbas BM, Abbas N, Osei-Bordom DC, Bach SP, Tripathi G, Rajoriya N

Expert Review of Gastroenterology & Hepatology2023 · Feb;17(2):168–173 · PMID: 36504933

Comprehensive expert review — precision medicine framework for cirrhotic surgical patients

Li W, Abbas N, Brennan PN, McDowell H, et al.

Frontline Gastroenterology2023 · Jan;14(3):316–335 · PMID: 37985329

National workforce survey — directly informing UK hepatology training policy

Hui RW, Abbas N, Dunne P, Tripathi D

Frontline Gastroenterology2023 · Sep;13(6):386–387 · PMID: 36687530

Expert clinical commentary — surgical risk optimisation in liver disease

Trainee Collaborative for Research and Audit In Hepatology UK [Including Abbas N]

Journal of Hepatology2023 · Jul;79(6):e85–e97 · PMID: 37310848

Journal of Hepatology — national collaborative; NASH-related decompensated cirrhosis

Trainee Collaborative for Research and Audit In Hepatology UK [Including Abbas N]

The Lancet Gastroenterology & Hepatology2023 · Jul;8(8):704–713 · PMID: 37148588

The Lancet Gastroenterology — major policy implications for cirrhosis service delivery

Corpechot C, Carrat F, Gaouar F, Abbas N, Trivedi P, et al. (Global & ERN Rare-Liver PBC Study Groups)

Journal of Hepatology2022 · Dec;77(6):1645–1650 · PMID: 35777381

Journal of Hepatology — 3,885 patients; 25 centres; 15 countries; landmark prognostic study

Rajoriya N, Abbas N, ElSharkawy AM, Chauhan A

Expert Review of Gastroenterology & Hepatology2022 · Jul;16(7):669–683 · PMID: 35796139

Invited expert review on emerging ACLF treatment paradigms

Abbas N, Quraishi MN, Trivedi P

Current Opinion in Pharmacology2022 · Feb;62:53–65 · PMID: 34904541

Comprehensive overview of novel therapeutic targets in PSC

Corrigan M, Thomas R, McDonagh J, … Abbas N, …, Rajoriya N

Frontline Gastroenterology2020 · Feb;11(2):108–112 · PMID: 32613041

Palliative cirrhosis management — real-world tunnelled ascites catheter outcomes

Hover to scroll · 21 publications total
Academic & Clinical

Institutional Affiliations

University Hospitals Birmingham NHS FT

Consultant Gastroenterologist & Hepatologist

University of Birmingham — Institute of Immunology & Immunotherapy

PhD · Centre for Liver and Gastrointestinal Research

NIHR Birmingham Biomedical Research Centre

Former Clinical Researcher — Liver & GI Theme

Global PBC Study Group

Contributing Investigator

ERN Rare–Liver (European Reference Network)

Contributing Member

British Society of Gastroenterology (BSG)

Fellow & Guidance Author — Liver Section

European Association for the Study of the Liver (EASL)

Member

British Association for Study of the Liver (BASL)

Member · Former National Trainee Chair

Recognition

Awards & Recognition

🏆
Dr Falk / Guts UK Awards 2023

SPR Trainee Audit & Quality Improvement Award Winner

British Society of Gastroenterology  ·  Guts UK

Nadir with Dr Riadh Jazrawi of Dr Falk and Prof Andy Veitch, BSG President

Nadir (centre) with Dr Riadh Jazrawi of Dr Falk (left) and Prof Andy Veitch, BSG President 2022–2024 (right)

Dr Nadir Abbas holding the award

Liverdojo.com — ‘Know Your Liver’

A nationally recognised patient education initiative: a multilingual website and YouTube channel providing accessible liver health information in commonly spoken UK languages — bridging the health literacy gap for BAME communities.

“Liverdojo.com will educate and empower both potential and diagnosed liver patients to make their own informed health choices and reduce the cost burden on the NHS.”

Developed alongside PhD research in cholestatic liver diseases at the Queen Elizabeth Hospital Liver Unit, University Hospital Birmingham NHS Trust. Received a £10,000 Guts UK / Dr Falk Charity Award and endorsement from both the BSG and BASL.

40

UK LIVER DEATHS DAILY

¾

CIRRHOSIS UNDIAGNOSED

2B

YOUTUBE USERS REACHED

Conferences

Conference & Academic Presentations

Dr Nadir Abbas presenting at BASL Annual Meeting

BASL Annual MeetingOral Presentation, Main Plenary

Second Opinion

Need a Liver Disease Second Opinion in the UK?

If you have been diagnosed with a liver condition or have abnormal liver tests, Dr Nadir Abbas offers specialist hepatology consultations and second opinions for complex liver disease.

Your Journey

Consultant-Led Pathway

1

Private Consultation

In this 30-minute session, Dr Abbas uses his PhD research background to find the root causes that standard tests often miss. This is the essential first step for anyone needing a definitive liver disease second opinion from a recognised UK expert.

2

Advanced Diagnostic Testing

Get a clear picture of your health with fast access to high-definition private gastroscopy or painless FibroScan technology. These tools allow Dr Abbas to check your digestive tract and measure liver scarring accurately without uncomfortable biopsies.

3

A PhD-Led Diagnosis

You will receive a straightforward explanation of your health, built on Dr Abbas’s role as a national lead in PBC and liver disease. This stage gives you a professional roadmap and total peace of mind about your future.

4

A Recovery Plan

Dr Abbas creates a plan just for you, which can include next-generation medicines (like Iqirvo or Ocaliva) not usually found in standard clinics. Whether reversing fatty liver or managing complex autoimmune conditions, our goal is to restore your health and energy.

Transparent Pricing

Know Your Costs Upfront

We believe you should always know the cost of your care upfront. Dr Abbas operates with a mandate of absolute honesty regarding all clinical fees.

Fixed Consultation Charges£250

Important Note: Any advanced diagnostic tests, such as painless FibroScan, high-definition endoscopy, or specialised blood panels, are priced and billed separately.

Testimonials

Feedback from Our Happy Patients

"We experienced high class service at House of Health from the doctors. Thank you for seeing us promptly."

M
MAVerified Patient

"House of Health is really just that! My experience has been nothing short of delightful and I am so happy I have discovered this clinic! The staff are warm and welcoming, the clinic is immaculate and the Dr's are extremely knowledgeable. This for me is a life changing service and I am so grateful."

A
AnonymousVerified Patient

"A seamless experience to date. The clinic is very well presented and a step up from my usual GP clinic. Dr Anita is lovely and really makes you feel heard. The patient coordinator Megan has been extremely helpful and always on hand to answer all of my queries."

L
LPVerified Patient

"Got an appointment for next day really quick. Dr. Sharan Wadhwani was incredibly professional and gave me a really quick diagnosis and weeks of fretting and worrying were over in seconds. The whole team were really polite and welcoming."

S
SSVerified Patient

"Great service! I was able to get an appointment the same day, and the whole process was easy and smooth. Highly recommend!"

A
ARVerified Patient

"From the moment you step into the clinic, the welcoming atmosphere and professionalism of the staff put you at ease. Dr. Raja is incredibly knowledgeable, attentive, and genuinely cares about your well being."

H
HAVerified Patient

"A wonderful clinic with caring, dedicated doctors. We have never experienced such care before. Efficient and high class."

B
BHVerified Patient

"I was able to book a same-day appointment online, which was incredibly convenient. The GP was absolutely lovely—so knowledgeable, attentive, and reassuring throughout the appointment. I felt truly listened to and cared for."

M
MSVerified Patient

"House of Health is a 5 star service. From booking, being seen by the doctor to medications – everything was a breeze. Thank you to the doctors for providing such a high quality service."

K
KCVerified Patient
Insurance

We Accept The Following Insurance

Bupa
Vitality
WPA
AXA
Get Started

Request a Callback

Fill out the form below and our team will get back to you to arrange your consultation.